ProMIS Neurosciences Inc. - Common Shares (PMN) analyst actions
Rating and price-target actions on PMN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the PMN overview →
1 measured PMN analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease | Press release | -1.96% | +0.98% |
Keep exploring
More PMN: earnings → · SEC filings → · PMN overview →